chr1-100468020-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_003672.4(CDC14A):​c.903T>C​(p.His301His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.011 in 1,613,124 control chromosomes in the GnomAD database, including 1,620 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.059 ( 891 hom., cov: 33)
Exomes 𝑓: 0.0061 ( 729 hom. )

Consequence

CDC14A
NM_003672.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.00

Publications

4 publications found
Variant links:
Genes affected
CDC14A (HGNC:1718): (cell division cycle 14A) The protein encoded by this gene is a member of the dual specificity protein tyrosine phosphatase family. It is highly similar to Saccharomyces cerevisiae Cdc14, a protein tyrosine phosphatase involved in the exit of cell mitosis and initiation of DNA replication, suggesting a role in cell cycle control. This protein has been shown to interact with, and dephosphorylate tumor suppressor protein p53, and is thought to regulate the function of p53. Alternative splicing of this gene results in several transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]
CDC14A Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic deafness 105
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • autosomal recessive nonsyndromic hearing loss 32
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, PanelApp Australia
  • hearing impairment and infertile male syndrome
    Inheritance: AR Classification: STRONG Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 1-100468020-T-C is Benign according to our data. Variant chr1-100468020-T-C is described in ClinVar as Benign. ClinVar VariationId is 517534.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.2 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDC14ANM_003672.4 linkc.903T>C p.His301His synonymous_variant Exon 10 of 16 ENST00000336454.5 NP_003663.2 Q9UNH5-1Q59EF4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDC14AENST00000336454.5 linkc.903T>C p.His301His synonymous_variant Exon 10 of 16 1 NM_003672.4 ENSP00000336739.3 Q9UNH5-1

Frequencies

GnomAD3 genomes
AF:
0.0584
AC:
8881
AN:
152148
Hom.:
886
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.203
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0202
Gnomad ASJ
AF:
0.00519
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.000661
Gnomad OTH
AF:
0.0420
GnomAD2 exomes
AF:
0.0154
AC:
3857
AN:
249854
AF XY:
0.0111
show subpopulations
Gnomad AFR exome
AF:
0.206
Gnomad AMR exome
AF:
0.00921
Gnomad ASJ exome
AF:
0.00687
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000839
Gnomad OTH exome
AF:
0.00776
GnomAD4 exome
AF:
0.00608
AC:
8880
AN:
1460858
Hom.:
729
Cov.:
31
AF XY:
0.00530
AC XY:
3850
AN XY:
726746
show subpopulations
African (AFR)
AF:
0.205
AC:
6809
AN:
33290
American (AMR)
AF:
0.0109
AC:
487
AN:
44560
Ashkenazi Jewish (ASJ)
AF:
0.00521
AC:
136
AN:
26104
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39648
South Asian (SAS)
AF:
0.000616
AC:
53
AN:
86064
European-Finnish (FIN)
AF:
0.0000749
AC:
4
AN:
53410
Middle Eastern (MID)
AF:
0.0134
AC:
77
AN:
5766
European-Non Finnish (NFE)
AF:
0.000447
AC:
497
AN:
1111662
Other (OTH)
AF:
0.0135
AC:
816
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
344
689
1033
1378
1722
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
210
420
630
840
1050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0585
AC:
8912
AN:
152266
Hom.:
891
Cov.:
33
AF XY:
0.0567
AC XY:
4220
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.203
AC:
8441
AN:
41514
American (AMR)
AF:
0.0199
AC:
305
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00519
AC:
18
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4826
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10622
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.000662
AC:
45
AN:
68026
Other (OTH)
AF:
0.0416
AC:
88
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
350
700
1051
1401
1751
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0232
Hom.:
211
Bravo
AF:
0.0655
Asia WGS
AF:
0.0110
AC:
38
AN:
3478
EpiCase
AF:
0.000709
EpiControl
AF:
0.00125

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Oct 05, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Aug 23, 2017
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.His301His in exon 10 of CDC14A: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence, and has been identified in 20.33% (2115/10404 ) of African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac. broadinstitute.org; dbSNP rs17122597). -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.13
DANN
Benign
0.49
PhyloP100
-2.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17122597; hg19: chr1-100933576; API